Clinical Trials Directory

Trials / Completed

CompletedNCT03151109

Glenoid Bone Grafting for RTSA: Clinical & Radiographic Outcomes

Glenoid Bone Grafting for Reverse Shoulder Arthroplasty: Clinical and Radiographic Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
67 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will look at patient radiographic and functional outcomes who have or will undergo a reverse, extended peg, shoulder arthroplasty (replacement) that requires the use of glenoid bone grafting.

Detailed description

Glenoid bone loss is a known issue with reverse shoulder implants and can lead to issues with implant fixation and stability over time. To address this issue an extended peg glenoid baseplate is used and area around plate is augmented with bone (auto or allo)graft material to encourage bony callous growth around the implant. This study is to look at this area of concern and determine if glenoid bone loss is occurring in the patients where these measures have been taken to deter its development.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCT ScanCT scan at minimum 1 year post op

Timeline

Start date
2016-09-01
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2017-05-12
Last updated
2022-02-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03151109. Inclusion in this directory is not an endorsement.